(Photo provided by Life Semantics)
“We will achieve full-scale sales growth through the full-scale B2B medical my data business, the release of B2C medical my data and non-face-to-face treatment solutions, and the commercialization of digital treatments.”
Seung-jae Song, CEO of Life Semantics, held a press conference in Yeouido, Seoul for listing on the KOSDAQ on the 4th, and said, “After listing, we will take a leap into a leading global digital health company through clinical promotion of the US Food and Drug Administration (FDA) based on successful domestic references. “He said.
Life Semantics is a digital health platform company founded in 2012. Through’Lifecode’, which provides common technologies such as creating, collecting, storing, and analyzing personal health data on a cloud basis, it is continuing the business of medical my data, digital treatment, and non-face-to-face treatment.
The core services provided are 11 types of data integration, data linkage between heterogeneous systems and devices, disease prediction artificial intelligence, knowledge contents, anonymization and encryption, security, and developer tools. Based on Life Record, the company has built a full lineup of business in the field of digital health, such as digital therapy, non-face-to-face treatment, and medical my data.
Digital therapeutics are high-quality software medical devices that replace and complement existing therapeutics to prevent, manage, and treat medical disorders or diseases. Lifesemantics’ lineup of digital therapeutic products is’Redpill Sumton’, a respiratory rehabilitation program, and’Red Peel Care’, a prognosis management program for cancer patients. Both products have been confirmed to have therapeutic effects through clinical trials at major domestic university hospitals. As the category for software medical devices was newly established in October last year, the company aims to complete the approval and approval from the Ministry of Food and Drug Safety within this year.
The B2B medical my data business is a business structure that targets key customers to provide core technologies, builds and manages digital health services, and receives API usage fees. The company is growing its business by signing contracts with major companies in the insurance, healthcare, and cloud fields such as Hanwha Life Insurance, Naver Cloud, and Body Friend. In addition, the LH Korea Land and Housing Corporation is planning to expand the business area into the construction field as it is promoting an intelligent home healthcare business for apartment residents.
Life Semantics was recognized for its technological prowess and business feasibility by obtaining an’A, A’grade in the technology evaluation in July last year, and the process of listing on the KOSDAQ began in earnest. The total number of IPO shares of Life Semantics is 100,000 shares, and the expected IPO price per share is 9000~12,500 won. It is expected to be listed at the end of this month after conducting demand forecasts for institutional investors on the 8th and 9th to determine the offering price, and after conducting a general subscription on the 11th to 12th. The representative organizer is Korea Investment & Securities.